Mosquito-borne Disease
Rice field development in Ivory Coast does not increase annual malaria rates
Published in Medical Letter on the CDC and FDA, June 29th, 2003
"In sub-Saharan Africa, lowlands developed for rice cultivation favor the development of Anopheles gambiae s.l. populations," researchers there explained. "However, the epidemiological impact is not clearly determined."
In a study conducted by M.C. Henry and coauthors at the Pierre Richet Institute in Bouake, "the importance of malaria was compared in terms of prevalence and parasite density of infections as well as in terms of disease incidence between three agroecosystems: uncultivated lowlands, 'R0', lowlands with one annual rice cultivation in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Clinical Trials
NCI and FDA announce joint program to streamline cancer drug development - Influenza Vaccine
Glycosylation has no impact on immunogenicity of DNA-based influenza vaccine - HIV/AIDS Prevention
Building evaluation capacity for HIV prevention programs outlined - HIV/AIDS Vaccine
Demand likely to outpace distribution of successful vaccine - Malaria
Anemia is maintained throughout parasitemia with Plasmodium vivax - Rheumatoid Arthritis Therapy
Infections caused by biologic treatments of rheumatoid arthritis - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
